Skip to main content
. 2023 Aug 24;9(3):210–220. doi: 10.5114/ceh.2023.130499

Fig. 1.

Fig. 1

ROC curve study to evaluate the performance of A) visfatin, and B) vaspin in the diagnosis of HCC in comparison to cirrhotic patients without HCC